Trishla Sinha

Trishla Sinha

Auto-generated profile, based on publicly available information

Trishla Sinha

Department of Genetics, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
AVArnau Vich Vila
Arnau Vich Vila
VCValerie Collij
Valerie Collij
SSSerena Sanna
Serena Sanna
TSTrishla Sinha
Trishla Sinha
FIFloris Imhann
Floris Imhann
RWRinse K. Weersma
Rinse K. Weersma
The human gut microbiota has now been associated with drug responses and efficacy, while chemical compounds present in these drugs can also impact the gut bacteria. However, drug–microbe interactions are still understudied in the clinical context, where polypharmacy and comorbidities co-occur. Here, we report relations between commonly used drugs and the gut microbiome. We performed metagenomics sequencing of faecal samples from a population cohort and two gastrointestinal disease cohorts. Differences between users and non-users were analysed per cohort, followed by a meta-analysis. While 19 of 41 drugs are found to be associated with microbial features, when controlling for the use of multiple medications, proton-pump inhibitors, metformin, antibiotics and laxatives show the strongest associations with the microbiome. We here provide evidence for extensive changes in taxonomy, metabolic potential and resistome in relation to commonly used drugs. This paves the way for future studies and has implications for current microbiome studies by demonstrating the need to correct for multiple drug use.

13 April 2022 in Nature
Verified
Journal Article
Closed access
PDF file
RGR. Gacesa
R. Gacesa
AKAlexander Kurilshikov
Alexander Kurilshikov
AVA. Vich Vila
A. Vich Vila
TST. Sinha
T. Sinha
MKM. A. Y. Klaassen
M. A. Y. Klaassen
RWR. K. Weersma
R. K. Weersma

29 October 2018 in Gut Microbes
Verified
Journal Article
Open access
TSTrishla Sinha
Trishla Sinha
AVArnau Vich Vila
Arnau Vich Vila
SGSanzhima Garmaeva
Sanzhima Garmaeva
SJSoesma A. Jankipersadsing
Soesma A. Jankipersadsing
FIFloris Imhann
Floris Imhann
AZAlexandra Zhernakova
Alexandra Zhernakova
Several gastrointestinal diseases show a sex imbalance, although the underlying (patho)physiological mechanisms behind this are not well understood. The gut microbiome may be involved in this process, forming a complex interaction with host immune system, sex hormones, medication and other environmental factors. Here we performed sex-specific analyses of fecal microbiota composition in 1135 individuals from a population-based cohort. The overall gut microbiome composition of females and males was significantly different (p = 0.001), with females showing a greater microbial diversity (p = 0.009). After correcting for the effects of intrinsic factors, smoking, diet and medications, female hormonal factors such as the use of oral contraceptives and undergoing an ovariectomy were associated with microbial species and pathways. Females had a higher richness of antibiotic-resistance genes, with the most notable being resistance to the lincosamide nucleotidyltransferase (LNU) gene family. The higher abundance of resistance genes is consistent with the greater prescription of the Macrolide-Lincosamide-Streptogramin classes of antibiotics to females. Furthermore, we observed an increased resistance to aminoglycosides in females with self-reported irritable bowel syndrome. These results throw light upon the effects of common medications that are differentially prescribed between sexes and highlight the importance of sex-specific analysis when studying the gut microbiome and resistome.

11 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
LCLianmin Chen
Lianmin Chen
VCValerie Collij
Valerie Collij
MJmartin Jaeger
martin Jaeger
IMInge C. L. van Den Munckhof
Inge C. L. van Den Munckhof
AVArnau Vich Vila
Arnau Vich Vila
JFJing Fu
Jing Fu
The gut microbiome is an ecosystem that involves complex interactions. Currently, our knowledge about the role of the gut microbiome in health and disease relies mainly on differential microbial abundance, and little is known about the role of microbial interactions in the context of human disease. Here, we construct and compare microbial co-abundance networks using 2,379 metagenomes from four human cohorts: an inflammatory bowel disease (IBD) cohort, an obese cohort and two population-based cohorts. We find that the strengths of 38.6% of species co-abundances and 64.3% of pathway co-abundances vary significantly between cohorts, with 113 species and 1,050 pathway co-abundances showing IBD-specific effects and 281 pathway co-abundances showing obesity-specific effects. We can also replicate these IBD microbial co-abundances in longitudinal data from the IBD cohort of the integrative human microbiome (iHMP-IBD) project. Our study identifies several key species and pathways in IBD and obesity and provides evidence that altered microbial abundances in disease can influence their co-abundance relationship, which expands our current knowledge regarding microbial dysbiosis in disease.

28 October 2019 in BMC Biology
Verified
Journal Article
Open access
PDF file
SGSanzhima Garmaeva
Sanzhima Garmaeva
TSTrishla Sinha
Trishla Sinha
AKAlexander Kurilshikov
Alexander Kurilshikov
JFJingyuan Fu
Jingyuan Fu
CWCisca Wijmenga
Cisca Wijmenga
AZAlexandra Zhernakova
Alexandra Zhernakova
The human gut harbors a complex ecosystem of microorganisms, including bacteria and viruses. With the rise of next-generation sequencing technologies, we have seen a quantum leap in the study of human-gut-inhabiting bacteria, yet the viruses that infect these bacteria, known as bacteriophages, remain underexplored. In this review, we focus on what is known about the role of bacteriophages in human health and the technical challenges involved in studying the gut virome, of which they are a major component. Lastly, we discuss what can be learned from studies of bacteriophages in other ecosystems.

15 April 2023 in Current Opinion in Microbiology
Verified
Journal Article
Open access
TSTrishla Sinha
Trishla Sinha
SBSiobhan Brushett
Siobhan Brushett
JPJelmer Prins
Jelmer Prins
AZAlexandra Zhernakova
Alexandra Zhernakova
There is growing knowledge that the maternal gut microbiome undergoes substantial changes during pregnancy. However, despite the recognition that the maternal gut microbiome influences maternal and infant health, we still have a limited understanding of the clinical and environmental factors that can impact the maternal gut microbiome during pregnancy and the consequences of these changes. Here, we review the current body of knowledge about factors shaping the maternal gut microbiome during pregnancy and its role in the development of pregnancy complications and infant health.